Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P16INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysis

21 Jun 2018

Abstract excerpt

Background This meta‐analysis was conducted to investigate the diagnostic performance of P16INK4a gene promoter methylation as a biomarker of non‐small cell lung cancer (NSCLC). Methods Two reviewers independently searched the Web of Science, PubMed, Cochrane, Embase, China National Knowledge Infrastructure, and Chinese Biomedical Literature databases. Publications relevant to P16INK4a gene promoter methylation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Lung Cancer Diagnosis and Treatment
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29927090
DOI: 10.1111/1759-7714.12783

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P16INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysisPMID 29927090Read ↗

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateSemantic proximity Read ↗

MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta‐analysisSemantic proximity Read ↗

Prognostic Significance of Potential Target Networks and P16INK4a In Early Diagnosis of Non-Small Cell Lung CancerSemantic proximity Read ↗

Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non‐small cell lung cancer: A meta‐analysisSemantic proximity Read ↗

A Panel of DNA Methylation Biomarkers for Detection and Improving Diagnostic Efficiency of Lung CancerSemantic proximity Read ↗

Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.Semantic proximity Read ↗

O-6-methylguanine-DNA methyltransferase gene promoter methylation and lung cancer risk: A meta-analysis.Semantic proximity Read ↗

DNA methylation and nonsmall cell lung cancer.Semantic proximity Read ↗

The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC)Semantic proximity Read ↗

Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implicationsSemantic proximity Read ↗

Exploring the Efficacy and Feasibility of using Biomarkers for Early Screening of Lung Cancer and their Potential Reverberation on Mortality Rate: A ReviewSemantic proximity Read ↗

Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.